⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

ABT

Abbott Laboratories

Healthcare · Medical Devices

103.70USD

+1.1900 (+1.16%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on ABT.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End03/2026 Q1
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 103.70
P/E28.8
Dvd Ind Yld2.4%
P/B3.47
P/S4.0
Curr EV/T12M EBITDA22.6
Mkt Cap (USD)180.6B
Curr EV (USD)207.2B
2)

Per Share Data

EPS T12M3.58
DPS2.40
Bk Val Per Sh29.54
Rev/Sh25.83
Cash/Sh3.24
Curr Shares Out1,741.8M
FCF/Sh4.22
3)

Cash Flow Analysis

P/CF19.1
Curr P/FCF24.5
CF/NI1.5
Dvd P/O66.7%
Cash Gen/Cash Reqd1.5
Csh Dvd Cov2.3
CFO/Sales21.0%
Eff Interest Rate2.3%
4)

Growth Potential

Dil EPS 1Y Gr-51.3%
Cap 1Y Gr5.3%
BPS 1Y Gr9.4%
R&D To Sales6.6%
Retention Rate33.3%
Rev 1Y Gr5.7%
FCF 1Y Gr16.4%
Assets 1Y Gr6.5%
5)

Profitability

EBITDA9.2B
EBIT7.7B
Operating Margin17.1%
Pretax Margin18.0%
Net Margin13.9%
ROA6.5%
ROE12.4%
ROC6.9%
Asset Turnover0.47
6)

Structure

Current Ratio1.39
Quick Ratio—
Debt/Assets30.8%
Debt/Com Eq65.4%
Net Debt/EBITDA2.97
Tot Debt/Capital39.5%
Gross Margin56.3%
EBIT/Int Exp14.4

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.